Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Paul M. who wrote (862)	11/22/1997 3:58:00 AM
From: Paul M.	Respond to of 7041

Correction: Sepracor (SEPR)

To: Paul M. who wrote (862)	11/22/1997 9:47:00 AM
From: BigKNY3	Read Replies (1) \| Respond to of 7041

Asensio's press release and report were not your normal "strong buy" or "strong sell" recommendation. He accused Zonagen of fraud and still is. He based this conclusion "as a result of Zonagen's highly selective disclosures.. and failure to disclose material". In this report, Asensio failed to disclosed his own short position in a hedge fund and failed to disclose a major Zonagen agreement with a major pharmaceutical company that might invalidate and hurt his position. Given the accusations in his press release and the timing of this release, the failure to disclose this information is inaccusable and hopefully illegal. Asensio is still in a state of denial and refuses to acknowledge his mistakes. One additional point, it is clear that Asensio doesn't understand the pharmaceutical industry and how it operates. He bases much of his conclusion that "Zonagen nor any of its investigators ever published complete medical papers for peer review". Asensio doesn't know that these papers are written only after Phase III clinical studies are completed. Then, the peer review process of medical journals takes an additional 3-18 months. New pharmaceuticals are approved on the basis of data analysis reviewed by the FDA not published articles. These articles are normally available soon after product approval... not before. Although I do not own Zonagen (in fact I own Pfizer), I am shocked by what Asensio has done and hope that the proper authorities take action. As investors, we should not take the attitude that Asensio's actions are part of normal everyday business. If you are going to attack a company on the basis of "selected disclosures" and fraud, you better have the evidence, proper understanding of the industry and provide full disclosure of the possible motivations behind your actions. BigKNY3

To: Paul M. who wrote (862)	11/23/1997 9:30:00 PM
From: Anaxagoras	Respond to of 7041

<<Mike, I agree with you 100%. SGP has billions in cash.>> In today's world it's a mistake to make ridiculous comments that are easily refuted by facts. Go to Free Edgar, freeedgar.com, pick out Schering's latest 10-Q, look at the balance sheet, see the entry for cash and equivalents ($732 million)and realize the exageration- if you can't get the facts straight, what value should one place in your opinions? And $10 million isn't spare change for anyone, especially when they're committed to another $40 million plus contingent upon approval and labelling. Anaxagoras